Marie Asano

Our mission is to build a net-positive food system by accelerating the protein transition with the ambition of not just being an alternative to current problems but successors by creating value chains that integrate what matters and empowering people to be part of this change.

Mogu is an innovation-driven design company changing the way things are traditionally made. We do this by partnering with our surrounding life-systems. Lead by the principles of Circular Economy and by the certainty that Nature’s intelligence can help us to radically disrupt the design of everyday products, mogu develops mycelium technologies and commercialises innovative products and groundbreaking solutions for everyday use in interiors and architecture. Rooted in growth and cultivation and guided by a strong product-driven approach, mogu products are the result of continuous and iterative R&D on mycelium technology, allowing to deliver responsible and renewable solutions, without compromising performance. Mogu is part of the SQIM technology holding which has the aim of further widening along time the multiple opportunities emerging from R&D activities, and therefore expanding on the true potential of mycelium-based technologies in concretely impacting additional fields and markets, thereby creating a real positive impact in people’s life. Mogu offers today the first commercial mycelium-based products on the market, suitable for interior design applications.

INAM is a Berlin-based, globally active organisation, founded by industry leaders, research institutes, investors and public offices to accelerate deep tech startups and help complex innovations reach their target audience. INAM created an inspiring ecosystem for high-tech businesses where industry leaders and investors meet entrepreneurs working on innovations and benefit from each others skill-set. INAM regularly organizes tech-focussed events to inspire, learn and work together in order to foster innovation. This includes the startup programmes AdMaLab, AdMaCom and AdMaCom Scale for pre-seed, seed and series A stage deep tech startups respectively. INAM also masterminded the „Future of Computing“ conference, which brings together research, startups corporates and investors to explore the best materials solutions to enhance computing performance. INAM also produces a regular podcast, Start Up the Science, which you can listen to on our website: https://www.inam.berlin/podcast or subscribe to on Spotify https://goo.gl/dsFRKP or iTunes https://goo.gl/acDgys IMPRESSUM: https://www.inam.berlin/impressum

Through pioneering life science and artificial intelligence, we developed our unique Nuritas MagnifierNπΦ platform that allows us to identify, unlock, clinically test and patent peptides; turning them into powerful and precise ingredients that elevate natural efficacy. We want to empower people to live healthier lives, naturally by making our everyday products healthier, safer, greener and more efficacious. From what we eat, to what we apply to our skin. By translating nature’s wisdom into innovation, together, we can change the life of billions.

Aphea.Bio is dedicated to food security and ensuring a safe and healthy food chain. We aim to provide novel, science-based solutions to build the agriculture of the future: sustainable, reliable and profitable. Located in Gent, Belgium, we have a highly dedicated and qualified team of scientist and industry experts. Based on our unique high throughput R&D platform utilizing the untapped microbial space, we have been able to build a broad pipeline based on naturally occurring micro-organisms. Our solutions range from biostimulants to biocontrol, and focus mainly on row crops. Our key strength is flexibility, which allows us to quickly adapt to market needs and to provide tailored solutions. We believe that with a fresh and sincere spirit of innovation, result-driven science, and the courage to go off the beaten track, there is fertile ground to develop efficacious biological solutions to help complement or partially replace products in the major chemical indications.

Kumovis is more than just another 3D printer manufacturer. Since its founding in 2017, the Munich-based start-up has been working on end-to-end workflows specifically designed to transform medical manufacturing and thus improve patient care. Kumovis has developed 3D printing technology for this purpose and combined it with clean room technology. Be it in the industrial or surgical environment, the focus is on the economical production of functionalized as well as patient-matched implants and instruments made of high-performance polymers. Kumovis also provides medical device companies and hospitals with a regulatory roadmap and documentation, enabling next-gen medtech to benefit patients faster.

LOEWI is powered by bioniq since 2022! We empower people to be the healthiest version of themselves by making personalized health transparent and accessible. We analyze micro- and macronutrients through finger-prick blood tests, visualize the results through a health platform and offer personalized diet recommendations and personalized supplements to match individual needs. Thereby we apply renowned methods of the sports medical examination center in Munich to provide a user-centric and end-to-end concept for our clients. https://bioniq.com/en/linkedin

LOEWI is powered by bioniq since 2022! We empower people to be the healthiest version of themselves by making personalized health transparent and accessible. We analyze micro- and macronutrients through finger-prick blood tests, visualize the results through a health platform and offer personalized diet recommendations and personalized supplements to match individual needs. Thereby we apply renowned methods of the sports medical examination center in Munich to provide a user-centric and end-to-end concept for our clients. https://bioniq.com/en/linkedin

With the scanfeld® system Grandperspective provides the worlds first early warning solution for hazardous gases that covers complete industrial sites. Based on our optical sensor units that identify a multitude of chemicals from the distance, we visualize and locate hazardous gas clouds and warn in real time against gas leaks and fugitive emissions. Grandperspective is a young company rich in experience. Our know-how in the development and application of remote sensing systems has been developed over years of working with plant operators and first responders all over the world. scanfeld bundles this knowledge into an innovative solution for the remote monitoring of plants of any size. The scanfeld early warning solution combines a novel detection system with an intelligent software package to form world’s first remote monitoring solution that is completely automated. Hundreds of different chemicals are identified from kilometers distance by passive FTIR spectroscopy. Large areas such as production sites, storage or transportation areas are monitored with just a handful of sensor units. Gas leaks are quickly detected and the distribution of hazardous gas clouds is monitored and visualized in real-time. The fully automated early warning solution is designed for the control room of the plant. It delivers an intuitive visualization of gas clouds and a mapping of hazard zones. It provides additional safety barriers and helps to mitigate the effects of gas release events.

Belyntic creates novel vaccines for viral diseases with unmet medical need. We have developed and validated a new platform technology, that generates self-adjuvant synthetic long peptides for a safe and durable induction of cellular immunity.

Belyntic creates novel vaccines for viral diseases with unmet medical need. We have developed and validated a new platform technology, that generates self-adjuvant synthetic long peptides for a safe and durable induction of cellular immunity.

We provide a novel sensor technology based on ambient mass spectrometry which does not only improve the utilization in traditional laboratory environments, but also enables the transfer of this kind of sensor technology to industrial process control, forensics, security technology (drugs, explosives, etc.) and the medical "point of care"​ diagnostics. Upgrading your MS with our patented SICRIT® technique turns your MS into a sensor that allows for a large range of new scientific and industrial applications of mass spectrometry. Contact us at: info (at) plasmion.de

Kumovis is more than just another 3D printer manufacturer. Since its founding in 2017, the Munich-based start-up has been working on end-to-end workflows specifically designed to transform medical manufacturing and thus improve patient care. Kumovis has developed 3D printing technology for this purpose and combined it with clean room technology. Be it in the industrial or surgical environment, the focus is on the economical production of functionalized as well as patient-matched implants and instruments made of high-performance polymers. Kumovis also provides medical device companies and hospitals with a regulatory roadmap and documentation, enabling next-gen medtech to benefit patients faster.

VEGDOG - vegan dog food is the first to 100% herbal and gluten-free complete feed for dogs , which was developed in a year-long development phase in cooperation with specialist veterinarians and specialized laboratories. Our different foods provide the dog with all essential nutrients and are required to cover. We use only local, high quality ingredients that are carefully processed and subject to the highest quality standards for a tasty food. VEGDOG is free of attractants, dyes, and preservatives and waived course on animal testing. Besides the high quality forage the VEGDOG PRODUCTS make an important contribution to animal welfare and environmental protection.

Our mission is to build a net-positive food system by accelerating the protein transition with the ambition of not just being an alternative to current problems but successors by creating value chains that integrate what matters and empowering people to be part of this change.

Mogu is an innovation-driven design company changing the way things are traditionally made. We do this by partnering with our surrounding life-systems. Lead by the principles of Circular Economy and by the certainty that Nature’s intelligence can help us to radically disrupt the design of everyday products, mogu develops mycelium technologies and commercialises innovative products and groundbreaking solutions for everyday use in interiors and architecture. Rooted in growth and cultivation and guided by a strong product-driven approach, mogu products are the result of continuous and iterative R&D on mycelium technology, allowing to deliver responsible and renewable solutions, without compromising performance. Mogu is part of the SQIM technology holding which has the aim of further widening along time the multiple opportunities emerging from R&D activities, and therefore expanding on the true potential of mycelium-based technologies in concretely impacting additional fields and markets, thereby creating a real positive impact in people’s life. Mogu offers today the first commercial mycelium-based products on the market, suitable for interior design applications.

INAM is a Berlin-based, globally active organisation, founded by industry leaders, research institutes, investors and public offices to accelerate deep tech startups and help complex innovations reach their target audience. INAM created an inspiring ecosystem for high-tech businesses where industry leaders and investors meet entrepreneurs working on innovations and benefit from each others skill-set. INAM regularly organizes tech-focussed events to inspire, learn and work together in order to foster innovation. This includes the startup programmes AdMaLab, AdMaCom and AdMaCom Scale for pre-seed, seed and series A stage deep tech startups respectively. INAM also masterminded the „Future of Computing“ conference, which brings together research, startups corporates and investors to explore the best materials solutions to enhance computing performance. INAM also produces a regular podcast, Start Up the Science, which you can listen to on our website: https://www.inam.berlin/podcast or subscribe to on Spotify https://goo.gl/dsFRKP or iTunes https://goo.gl/acDgys IMPRESSUM: https://www.inam.berlin/impressum

ECBF is a growth-stage venture capital fund established in Luxembourg dedicated to growth-stage investments within the European Circular Bioeconomy. We bring Europes circular technologies to market, identifying the most promising investment targets, and syndicating with private and public investors to join financial rounds. Our mission is to provide access to finance to innovative solutions that enable the transitioning from a linear economy to a more sustainable circular one, having the European Investment Bank as a cornerstone investor. Our targeted investment sectors include new technologies and business models in Agtech; blue economy; and bio-based chemicals, specialities and materials; with applications on Nutrition; packaging, personal care, construction, and textiles. Investment opportunities in circularity -i.e., conversion of biological resources and waste streams into value-added products- have a high priority. We believe that investing now in circular businesses and technologies will be beneficial to both a growing market segment and a cleaner future.